192 related articles for article (PubMed ID: 15149859)
1. The small leucine-rich proteoglycan lumican inhibits melanoma progression.
Vuillermoz B; Khoruzhenko A; D'Onofrio MF; Ramont L; Venteo L; Perreau C; Antonicelli F; Maquart FX; Wegrowski Y
Exp Cell Res; 2004 Jun; 296(2):294-306. PubMed ID: 15149859
[TBL] [Abstract][Full Text] [Related]
2. Lumican inhibits B16F1 melanoma cell lung metastasis.
Brezillon S; Zeltz C; Schneider L; Terryn C; Vuillermoz B; Ramont L; Perrau C; Pluot M; Diebold MD; Radwanska A; Malicka-Blaszkiewicz M; Maquart FX; Wegrowski Y
J Physiol Pharmacol; 2009 Oct; 60 Suppl 4():15-22. PubMed ID: 20083847
[TBL] [Abstract][Full Text] [Related]
3. Role of the small leucine-rich proteoglycan (SLRP) family in pathological lesions and cancer cell growth.
Naito Z
J Nippon Med Sch; 2005 Jun; 72(3):137-45. PubMed ID: 16046829
[TBL] [Abstract][Full Text] [Related]
4. Enhanced expression of lumican inhibited the attachment and growth of human embryonic kidney 293 cells.
Ishiwata T; Yamamoto T; Kawahara K; Kawamoto Y; Matsuda Y; Ishiwata S; Naito Z
Exp Mol Pathol; 2010 Jun; 88(3):363-70. PubMed ID: 20138170
[TBL] [Abstract][Full Text] [Related]
5. Lumican Inhibits SNAIL-Induced Melanoma Cell Migration Specifically by Blocking MMP-14 Activity.
Stasiak M; Boncela J; Perreau C; Karamanou K; Chatron-Colliet A; Proult I; Przygodzka P; Chakravarti S; Maquart FX; Kowalska MA; Wegrowski Y; Brézillon S
PLoS One; 2016; 11(3):e0150226. PubMed ID: 26930497
[TBL] [Abstract][Full Text] [Related]
6. Lumican: a new inhibitor of matrix metalloproteinase-14 activity.
Pietraszek K; Chatron-Colliet A; Brézillon S; Perreau C; Jakubiak-Augustyn A; Krotkiewski H; Maquart FX; Wegrowski Y
FEBS Lett; 2014 Nov; 588(23):4319-24. PubMed ID: 25304424
[TBL] [Abstract][Full Text] [Related]
7. Identification of beta1 integrin as mediator of melanoma cell adhesion to lumican.
D'Onofrio MF; Brézillon S; Baranek T; Perreau C; Roughley PJ; Maquart FX; Wegrowski Y
Biochem Biophys Res Commun; 2008 Jan; 365(2):266-72. PubMed ID: 17981144
[TBL] [Abstract][Full Text] [Related]
8. Expression of lumican, a small leucine-rich proteoglycan with antitumour activity, in human malignant melanoma.
Brézillon S; Venteo L; Ramont L; D'Onofrio MF; Perreau C; Pluot M; Maquart FX; Wegrowski Y
Clin Exp Dermatol; 2007 Jul; 32(4):405-16. PubMed ID: 17490399
[TBL] [Abstract][Full Text] [Related]
9. Lumican, a small leucine-rich proteoglycan substituted with keratan sulfate chains is expressed and secreted by human melanoma cells and not normal melanocytes.
Sifaki M; Assouti M; Nikitovic D; Krasagakis K; Karamanos NK; Tzanakakis GN
IUBMB Life; 2006 Oct; 58(10):606-10. PubMed ID: 17050378
[TBL] [Abstract][Full Text] [Related]
10. Lumican core protein inhibits melanoma cell migration via alterations of focal adhesion complexes.
Brézillon S; Radwanska A; Zeltz C; Malkowski A; Ploton D; Bobichon H; Perreau C; Malicka-Blaszkiewicz M; Maquart FX; Wegrowski Y
Cancer Lett; 2009 Sep; 283(1):92-100. PubMed ID: 19394140
[TBL] [Abstract][Full Text] [Related]
11. Lumican inhibits cell migration through α2β1 integrin.
Zeltz C; Brézillon S; Käpylä J; Eble JA; Bobichon H; Terryn C; Perreau C; Franz CM; Heino J; Maquart FX; Wegrowski Y
Exp Cell Res; 2010 Oct; 316(17):2922-31. PubMed ID: 20705068
[TBL] [Abstract][Full Text] [Related]
12. Lumican suppresses cell proliferation and aids Fas-Fas ligand mediated apoptosis: implications in the cornea.
Vij N; Roberts L; Joyce S; Chakravarti S
Exp Eye Res; 2004 May; 78(5):957-71. PubMed ID: 15051477
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of lumican affects the migration of human colon cancer cells through up-regulation of gelsolin and filamentous actin reorganization.
Radwanska A; Litwin M; Nowak D; Baczynska D; Wegrowski Y; Maquart FX; Malicka-Blaszkiewicz M
Exp Cell Res; 2012 Nov; 318(18):2312-23. PubMed ID: 22814255
[TBL] [Abstract][Full Text] [Related]
14. Lumican - derived peptides inhibit melanoma cell growth and migration.
Pietraszek K; Brézillon S; Perreau C; Malicka-Błaszkiewicz M; Maquart FX; Wegrowski Y
PLoS One; 2013; 8(10):e76232. PubMed ID: 24098450
[TBL] [Abstract][Full Text] [Related]
15. Lumican affects actin cytoskeletal organization in human melanoma A375 cells.
Radwanska A; Baczynska D; Nowak D; Brézillon S; Popow A; Maquart FX; Wegrowski Y; Malicka-Blaszkiewicz M
Life Sci; 2008 Nov; 83(19-20):651-60. PubMed ID: 18848571
[TBL] [Abstract][Full Text] [Related]
16. Lumican expression is positively correlated with the differentiation and negatively with the growth of human osteosarcoma cells.
Nikitovic D; Berdiaki A; Zafiropoulos A; Katonis P; Tsatsakis A; Karamanos NK; Tzanakakis GN
FEBS J; 2008 Jan; 275(2):350-61. PubMed ID: 18093185
[TBL] [Abstract][Full Text] [Related]
17. Lumcorin: a leucine-rich repeat 9-derived peptide from human lumican inhibiting melanoma cell migration.
Zeltz C; Brézillon S; Perreau C; Ramont L; Maquart FX; Wegrowski Y
FEBS Lett; 2009 Sep; 583(18):3027-32. PubMed ID: 19686741
[TBL] [Abstract][Full Text] [Related]
18. Regulation of corneal collagen fibrillogenesis in vitro by corneal proteoglycan (lumican and decorin) core proteins.
Rada JA; Cornuet PK; Hassell JR
Exp Eye Res; 1993 Jun; 56(6):635-48. PubMed ID: 8595806
[TBL] [Abstract][Full Text] [Related]
19. Distinctive localization and function for lumican, fibromodulin and decorin to regulate collagen fibril organization in periodontal tissues.
Matheson S; Larjava H; Häkkinen L
J Periodontal Res; 2005 Aug; 40(4):312-24. PubMed ID: 15966909
[TBL] [Abstract][Full Text] [Related]
20. Role of lumican in cancer cells and adjacent stromal tissues in human pancreatic cancer.
Ishiwata T; Cho K; Kawahara K; Yamamoto T; Fujiwara Y; Uchida E; Tajiri T; Naito Z
Oncol Rep; 2007 Sep; 18(3):537-43. PubMed ID: 17671699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
